Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 28912 | 196 | 36.1 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 17 | 4 | REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES | 563730 |
| 132 | 3 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//OBSTETRICS & GYNECOLOGY | 66807 |
| 1096 | 2 | SERTOLI CELLS//TESTIS//SPERMATOGONIAL STEM CELLS | 9824 |
| 28912 | 1 | BIOCHEM NUTR METAB DISORDERS//REPROD ENDOCRINOL FAMILY WELFARE UNIT//ADULT MALE PROGENY | 196 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BIOCHEM NUTR METAB DISORDERS | address | 280425 | 2% | 60% | 3 |
| 2 | REPROD ENDOCRINOL FAMILY WELFARE UNIT | address | 200302 | 2% | 43% | 3 |
| 3 | ADULT MALE PROGENY | authKW | 155793 | 1% | 100% | 1 |
| 4 | BIOMED INVEST INBIOMED | address | 155793 | 1% | 100% | 1 |
| 5 | CENT AREA BRANCH | address | 155793 | 1% | 100% | 1 |
| 6 | CISPALTIN CIS | authKW | 155793 | 1% | 100% | 1 |
| 7 | ELAZIG DIRECTORSHIP PUBL HLTH | address | 155793 | 1% | 100% | 1 |
| 8 | EPIDIDYMAL SPERM CHARACTERISTICS | authKW | 155793 | 1% | 100% | 1 |
| 9 | EPIDIDYMAL SPERM CONCENTRATION | authKW | 155793 | 1% | 100% | 1 |
| 10 | ESTROGEN GESTAGEN TREATMENT | authKW | 155793 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Andrology | 15480 | 18% | 0% | 35 |
| 2 | Toxicology | 1227 | 24% | 0% | 47 |
| 3 | Reproductive Biology | 675 | 12% | 0% | 23 |
| 4 | Urology & Nephrology | 130 | 8% | 0% | 16 |
| 5 | Pharmacology & Pharmacy | 125 | 17% | 0% | 33 |
| 6 | Anatomy & Morphology | 87 | 3% | 0% | 6 |
| 7 | Obstetrics & Gynecology | 50 | 6% | 0% | 11 |
| 8 | Pathology | 28 | 4% | 0% | 8 |
| 9 | Endocrinology & Metabolism | 14 | 5% | 0% | 9 |
| 10 | Biology | 13 | 3% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOCHEM NUTR METAB DISORDERS | 280425 | 2% | 60% | 3 |
| 2 | REPROD ENDOCRINOL FAMILY WELFARE UNIT | 200302 | 2% | 43% | 3 |
| 3 | BIOMED INVEST INBIOMED | 155793 | 1% | 100% | 1 |
| 4 | CENT AREA BRANCH | 155793 | 1% | 100% | 1 |
| 5 | ELAZIG DIRECTORSHIP PUBL HLTH | 155793 | 1% | 100% | 1 |
| 6 | MOL DRUG METAB TOXICOL UNIT | 155793 | 1% | 100% | 1 |
| 7 | PHYSIOL COMMUNITY HLTH | 155793 | 1% | 100% | 1 |
| 8 | PROGRAM ENVIRONM REG DEV | 155793 | 1% | 100% | 1 |
| 9 | SURG PATHOL 3 | 155793 | 1% | 100% | 1 |
| 10 | ANDROL INTEGRAT MED | 77896 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANDROLOGIA | 12352 | 8% | 1% | 15 |
| 2 | REPRODUCTIVE TOXICOLOGY | 5018 | 5% | 0% | 9 |
| 3 | JOURNAL OF ANDROLOGY | 4753 | 5% | 0% | 9 |
| 4 | ZEITSCHRIFT FUR SAUGETIERKUNDE-INTERNATIONAL JOURNAL OF MAMMALIAN BIOLOGY | 1434 | 2% | 0% | 3 |
| 5 | ANDROLOGY | 1242 | 1% | 0% | 2 |
| 6 | PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY | 1133 | 1% | 0% | 2 |
| 7 | ASIAN JOURNAL OF ANDROLOGY | 861 | 2% | 0% | 3 |
| 8 | JOURNAL OF ENVIRONMENTAL PATHOLOGY AND TOXICOLOGY | 845 | 1% | 1% | 1 |
| 9 | ARCHIVES OF ANDROLOGY | 790 | 2% | 0% | 3 |
| 10 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 780 | 2% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HUSSEIN, YM , MOHAMMED, RH , SHALABY, SM , ABD EL-HALEEM, MR , ABD EL MOTTELEB, DM , (2015) ANTI-OXIDATIVE AND ANTI-APOPTOTIC ROLES OF SPERMATOGONIAL STEM CELLS IN REVERSING CISPLATIN-INDUCED TESTICULAR TOXICITY.CYTOTHERAPY. VOL. 17. ISSUE 11. P. 1646 -1654 | 12 | 50% | 0 |
| 2 | TURK, G , CERIBASI, AO , SAHNA, E , ATESSAHIN, A , (2011) LYCOPENE AND ELLAGIC ACID PREVENT TESTICULAR APOPTOSIS INDUCED BY CISPLATIN.PHYTOMEDICINE. VOL. 18. ISSUE 5. P. 356-361 | 9 | 64% | 19 |
| 3 | KILARKAJE, N , (2014) EFFECTS OF COMBINED TREATMENT OF ALPHA-TOCOPHEROL, L-ASCORBIC ACID, SELENIUM AND ZINC ON BLEOMYCIN, ETOPOSIDE AND CISPLATIN-INDUCED ALTERATIONS IN TESTOSTERONE SYNTHESIS PATHWAY IN RATS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 74. ISSUE 6. P. 1175 -1189 | 14 | 34% | 1 |
| 4 | TURK, G , CCEDIL;ERIBASI, AO , SAKIN, F , SONMEZ, M , ATESSAHIN, A , (2010) ANTIPEROXIDATIVE AND ANTI-APOPTOTIC EFFECTS OF LYCOPENE AND ELLAGIC ACID ON CYCLOPHOSPHAMIDE-INDUCED TESTICULAR LIPID PEROXIDATION AND APOPTOSIS.REPRODUCTION FERTILITY AND DEVELOPMENT. VOL. 22. ISSUE 4. P. 587 -596 | 14 | 35% | 22 |
| 5 | SARAL, S , OZCELIK, E , CETIN, A , SARAL, O , BASAK, N , AYDIN, M , CIFTCI, O , (2016) PROTECTIVE ROLE OF DIOSPYROS LOTUS ON CISPLATIN-INDUCED CHANGES IN SPERM CHARACTERISTICS, TESTICULAR DAMAGE AND OXIDATIVE STRESS IN RATS.ANDROLOGIA. VOL. 48. ISSUE 3. P. 308 -317 | 10 | 43% | 0 |
| 6 | AHMED, EA , OMAR, HM , ABD ELGHAFFAR, SK , RAGB, SMM , NASSER, AY , (2011) THE ANTIOXIDANT ACTIVITY OF VITAMIN C, DPPD AND L-CYSTEINE AGAINST CISPLATIN-INDUCED TESTICULAR OXIDATIVE DAMAGE IN RATS.FOOD AND CHEMICAL TOXICOLOGY. VOL. 49. ISSUE 5. P. 1115 -1121 | 12 | 36% | 22 |
| 7 | BEYTUR, A , CIFTCI, O , OGUZ, F , OGUZTURK, H , YILMAZ, F , (2012) MONTELUKAST ATTENUATES SIDE EFFECTS OF CISPLATIN INCLUDING TESTICULAR, SPERMATOLOGICAL, AND HORMONAL DAMAGE IN MALE RATS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 69. ISSUE 1. P. 207-213 | 9 | 45% | 11 |
| 8 | FAVARETO, APA , FERNANDEZ, CD , DA SILVA, DAF , ANSELMO-FRANCI, JA , KEMPINAS, WD , (2011) PERSISTENT IMPAIRMENT OF TESTICULAR HISTOLOGY AND SPERM MOTILITY IN ADULT RATS TREATED WITH CISPLATIN AT PERI-PUBERTY.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 109. ISSUE 2. P. 85 -96 | 14 | 27% | 9 |
| 9 | CASTRO, MAS , FERREIRA, U , GLINA, S , CASTRO, ACS , MATHEUS, WE , REIS, LO , (2010) TESTICULAR COMPONENTS VOLUME DENSITY ALTERATION ASSOCIATED TO CIS-PLATINUM: CAN ANTIOXIDANTS OFFER PROTECTION?.ACTAS UROLOGICAS ESPANOLAS. VOL. 34. ISSUE 3. P. 282 -287 | 6 | 67% | 2 |
| 10 | NARAYANA, K , (2010) CISPLATIN INDUCES DUPLEX 3 ' OVERHANGS AND 5 ' BLUNT ENDS IN EPIDIDYMAL EPITHELIUM IN A BAX-DEPENDENT MANNER WITHOUT ANY PROTECTION FROM L-ASCORBIC ACID.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 641. ISSUE 2-3. P. 238-245 | 13 | 28% | 5 |
Classes with closest relation at Level 1 |